Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US

Launched by UNIVERSITY OF CONNECTICUT · Apr 1, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how stigma and substance use affect the use of pre-exposure prophylaxis (PrEP), a medication that helps prevent HIV, among Black men and transwomen in the Southeastern United States. The researchers want to understand the barriers that may prevent these individuals from using PrEP, especially those who identify as part of the Black sexual minority community and who may also use substances. By gathering this information, the study aims to improve strategies for reducing HIV rates in these groups.

To be eligible for the trial, participants must be at least 18 years old, identify as Black or part of the African diaspora, and have had condomless anal sex with a man in the last six months. They also need to be HIV negative and have used substances recently. If you choose to participate, you can expect to share your experiences and feelings about PrEP and stigma, which will help researchers develop better support and resources for people in similar situations. The trial is currently recruiting participants, so if you meet the criteria, you may have the opportunity to contribute to important research in HIV prevention.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Men (based on male sex assignment at birth)
• • Age 18 or older
• • Identify as Black, African-American, Afro-Brazilian, Afro-Carribean, or African diaspora,
• • Report condomless anal sex with man in past six months
• • Test HIV negative
• • Report recent (\<3 months) substance use
• • Positive drug toxicology for substance use
• Exclusion Criteria:
• • -